Učitavanje...
Profile of a Novel Anionic Fluoroquinolone—Delafloxacin
Fluoroquinolones have been in clinical use for over 50 years with significant efficacy. However, increasing resistance and emergence of some marked adverse events have limited their usage. The most recently approved class member, delafloxacin, is the only available anionic (non-zwitterionic) fluoroq...
Spremljeno u:
| Izdano u: | Clin Infect Dis |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6452001/ https://ncbi.nlm.nih.gov/pubmed/30957164 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy1079 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|